JunHe LLP

Follow

In review: court procedure in China

February 17 2022 A general introduction to court procedure in China, including key considerations surrounding time frames, representation in proceedings, access to court files and much more.

At a glance: pharmaceutical merger review in China

July 1 2021 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in China, including review triggers and thresholds.

Spotlight: alternatives to litigation in China

February 17 2022 A general introduction to alternative dispute resolution methods in China, covering key considerations surrounding arbitration, mediation and other mechanisms.

Spotlight: discontinuing employment in China

March 11 2020 A review of key considerations when discontinuing employment in China, including issues surrounding dismissals, redundancies and other types of termination.

In brief: anticompetitive agreements in the pharmaceutical sector in China

July 1 2021 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in China, including the assessment framework and special issues with vertical agreements.

Spotlight: alternatives to litigation in China

February 17 2022 A general introduction to alternative dispute resolution methods in China, covering key considerations surrounding arbitration, mediation and other mechanisms.

In review: court procedure in China

February 17 2022 A general introduction to court procedure in China, including key considerations surrounding time frames, representation in proceedings, access to court files and much more.

In review: recent trade law developments in China

September 30 2021 A general survey of recent legal and practical developments affecting international trade in China, including legislative and policy changes and noteworthy trade disputes.

Spotlight: international trade law in China

September 30 2021 An examination of the most consequential features of the legal framework governing international trade in China, covering key legislation, trade remedies, treaties and more.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in China

July 1 2021 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in China, including IP rights abuse and pricing conduct.